Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Clinical trial NCT00171873 · COMPLETED
Trial details
- NCT number
- NCT00171873
- Sponsor
- Carmen Schade-Brittinger
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Primary completion
- 2008-06-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.